European Capacity Building for Patients (EUCAPA) is a EU4Health Programme co-funded by the European Union, under call EU4H-2022-PJ, that will ensure that patients and patient organisations have the necessary knowledge of the HTA process to be meaningfully involved in HTA (both scientific consultations and assessments), as foreseen by the new Regulation on HTA (EU) 2021/2282 that will start assessing health technologies in January 2025. After undergoing the training programmes, patient experts will acquire the necessary skills, knowledge, and understanding of HTA, that will allow them to constructively participate and present their lived experience in assessing health technologies.
Company Details
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- http://www.eucapa.eu
- Keywords
- will contribute to assessments.
- Competitors
- EURORDIS-Rare Diseases Europe, European Cancer Patient Coalition, Cancer Patients Europe - CPE, European Association for Cancer Research (EACR), EUPATI, European Health and Digital Executive Agency (HaDEA), European Patients' Forum, International Consortium for Health Outcomes Measurement (ICHOM), Not Just Patients, European Cancer Organisation.
Eucapa Questions
Eucapa's website is http://www.eucapa.eu
Eucapa's LinkedIn profile is https://www.linkedin.com/company/eucapahta
Eucapa's industry is
Public Health
Eucapa's top competitors are
Eurordis-Rare Diseases Europe,
European Cancer Patient Coalition,
Cancer Patients Europe - Cpe,
European Association For Cancer Research (Eacr),
Eupati,
European Health And Digital Executive Agency (Hadea),
European Patients' Forum,
International Consortium For Health Outcomes Measurement (Ichom),
Not Just Patients,
European Cancer Organisation.
Eucapa's categories are Public Health
